A forum for researchers, students and applicants in the field of cyclodextrin technology
Rafael Holdings, Inc. announced that data from Cyclo Therapeutics’ Phase 3 TransportNPC™ open-label, single-arm sub-study evaluating Trappsol® Cyclo™ (hydroxypropyl-beta-cyclodextrin) for Niemann-Pick
It is a delightful coincidence that the product’s shape reflects the molecular structure of its key ingredient. In this short
HP-β-CD is currently under clinical investigation for treating Niemann-Pick disease type C (NPC), but its ototoxicity remains problematic. It was
According to data from China’s National Medical Products Administration (NMPA), Shandong Binzhou Zhiyuan Biotechnology Co., Ltd. successfully filed β-Cyclodextrin/Epichlorohydrin Crosspolymer
This study examines suboptimal formulation practices involving cyclodextrins (CDs) in medicinal products across the post-Soviet region, with a focus on
This multicentre, randomised, double-blind, positive-controlled, noninferiority phase III clinical trial aimed to investigate the efficacy and safety of adamagammadex compared
Clinical trial NCT07079761 may help us understand treatable factors that increase risk for chronic or treatment-resistant Post Traumatic Stress Disorder
Manuka honey is renowned for its health-promoting properties, with well-documented medicinal uses. When combined with α-cyclodextrin it forms a specialized
45 years ago, Szejtli et al. reported on the synthesis of heptakis(2,6-di-O-methyl)-beta-cyclodextrin using dimethyl sulfate as alkylating agent in a
“Maxi-tsai-persik” is a flavored black tea aromatised with peach extract and stabilized with E-459 (beta-cyclodextrin). The product is marketed in
